Literature DB >> 6420510

Isolation of Daudi cells with reduced sensitivity to interferon. I. Characterization.

M Dron, M G Tovey.   

Abstract

Treatment of Daudi cells with successively increasing concentrations of interferon-alpha resulted in the selection of a cell population which multiplied in the continued presence of 10(4) units/ml of interferon-alpha. A number of clones of interferon-resistant Daudi cells were isolated from this population. Two clones, DIF2 and DIF3, were found to exhibit moderate and pronounced resistance, respectively, to both the antiviral and antiproliferative actions of human interferons-alpha and -beta. These clones were also less responsive to the enhancement by interferon of Epstein-Barr virus early antigen expression. Both the surface antigens and karyotype of the interferon-resistant clones were similar to those of parental Daudi cells. After prolonged cultivation in the absence of interferon, DIF3 cells were found to 'revert' to an intermediate interferon sensitivity. The interferon sensitivity of clone DIF2 remained unchanged even after more than 1 year in culture.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6420510     DOI: 10.1099/0022-1317-64-12-2641

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  8 in total

1.  Sensitivity of an epstein-barr virus-positive tumor line, Daudi, to alpha interferon correlates with expression of a GC-rich viral transcript.

Authors:  Y Gao; S a Xue; B E Griffin
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

Review 2.  Regulation of cell proliferation and differentiation by interferons.

Authors:  M J Clemens; M A McNurlan
Journal:  Biochem J       Date:  1985-03-01       Impact factor: 3.857

Review 3.  Interferon receptors.

Authors:  A A Branca
Journal:  In Vitro Cell Dev Biol       Date:  1988-03

4.  Interferon modulation of c-myc expression in cloned Daudi cells: relationship to the phenotype of interferon resistance.

Authors:  M Dron; N Modjtahedi; O Brison; M G Tovey
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

5.  Priming affects the activity of a specific region of the promoter of the human beta interferon gene.

Authors:  M Dron; M Lacasa; M G Tovey
Journal:  Mol Cell Biol       Date:  1990-02       Impact factor: 4.272

6.  Use of a selectable marker regulated by alpha interferon to obtain mutations in the signaling pathway.

Authors:  S Pellegrini; J John; M Shearer; I M Kerr; G R Stark
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

7.  Increased rate of degradation of c-myc mRNA in interferon-treated Daudi cells.

Authors:  C Dani; N Mechti; M Piechaczyk; B Lebleu; P Jeanteur; J M Blanchard
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

8.  Cells resistant to interferon are defective in activation of a promoter-binding factor.

Authors:  D S Kessler; R Pine; L M Pfeffer; D E Levy; J E Darnell
Journal:  EMBO J       Date:  1988-12-01       Impact factor: 11.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.